Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.
Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.
The purpose of this narrative review is to summarize existing harm reduction strategies in the United States and elsewhere and to describe how outcomes of these strategies could be assessed.
This study evaluated factors associated with stigma related to injecting drug use (IDU) or HCV and those associated with being treated
This report summarizes the literature on ketamine as a treatment for adults with substance use disorders.
With the introduction of a needle syringe program (NSP) in Stockholm, Sweden and unrestricted availability of direct acting antiviral (DAA) treatment, we investigate
This study examines the impact of xylazine alone and in combination with fentanyl on several behaviors in mice.
The purpose of this study was to explore the social and relational factors that shape the current opioid overdose epidemic in the US.
This is a report on a study which sought to identify how many healthcare workers use stigmatizing language when writing about people with opioid use disorder in their
The objective of the study was to learn from the experiences of people who use drugs (PWUD) across Ontario to better understand how the Good Samaritan law is working
Contingency management (CM) is the most effective treatment for reducing methamphetamine use.
To discuss the implications of the prevalence of xylazine in the drug supply.
This study sought to compare palliative care provision for decedents with and without Opioid Use Disorder (OUD).
This paper discusses how fentanyl and the toxic drug supply complicates hospital Opioid Use Disorder (OUD) care.
This paper reviews what is known about the effects of opioid use disorder on decision-making, and argues that some subset of these refusals are non-autonomous choices
This report summarizes the first year of operations of two Overdose Prevention Centers (OPC) in NYC.